{"id":"NCT01677910","sponsor":"Lexicon Pharmaceuticals","briefTitle":"TELESTAR (Telotristat Etiprate for Somatostatin Analogue Not Adequately Controlled Carcinoid Syndrome)","officialTitle":"A Phase 3, Randomized, Placebo-controlled, Parallel Group, Multicenter, Double-blind Study to Evaluate the Efficacy and Safety of Telotristat Etiprate (LX1606) in Patients With Carcinoid Syndrome Not Adequately Controlled by Somatostatin Analog (SSA) Therapy","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-01-08","primaryCompletion":"2016-03-21","completion":"2016-03-21","firstPosted":"2012-09-03","resultsPosted":"2017-09-18","lastUpdate":"2018-02-27"},"enrollment":135,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Carcinoid Syndrome"],"interventions":[{"type":"DRUG","name":"Telotristat etiprate","otherNames":["LX1606"]},{"type":"DRUG","name":"Placebo-matching telotristat etiprate","otherNames":[]}],"arms":[{"label":"250 mg Telotristat Etiprate","type":"EXPERIMENTAL"},{"label":"500 mg Telotristat Etiprate","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"},{"label":"Telotristat Etiprate Open-Label Extension","type":"EXPERIMENTAL"}],"summary":"The primary objective of the study is to confirm that at least 1 or more doses of telotristat etiprate compared to placebo is effective in reducing the number of daily bowel movements (BMs) from baseline averaged over the 12-week double-blind portion (Treatment Period) of the trial in patients not adequately controlled by current SSA therapy.","primaryOutcome":{"measure":"Change From Baseline in the Number of Bowel Movements (BMs) Per Day Averaged Over 12 Weeks","timeFrame":"Baseline and 12 Weeks","effectByArm":[{"arm":"Placebo","deltaMin":-0.623,"sd":0.8275},{"arm":"250 mg Telotristat Etiprate","deltaMin":-1.433,"sd":1.3652},{"arm":"500 mg Telotristat Etiprate","deltaMin":-1.455,"sd":1.3098}],"pValues":[{"comp":"OG000 vs OG001","p":"< 0.001"},{"comp":"OG000 vs OG002","p":"< 0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":6},"locations":{"siteCount":75,"countries":["United States","Australia","Belgium","Canada","France","Germany","Israel","Italy","Netherlands","Spain","Sweden","United Kingdom"]},"refs":{"pmids":["34598813","32157590","32146619","31655936","30477789","29724499"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":7,"n":45},"commonTop":["Abdominal pain","Nausea","Fatigue","Vomiting","Decreased appetite"]}}